253 related articles for article (PubMed ID: 10694825)
1. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
Qu Z; Huard J
Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
3. Gene complementation using myoblast transfer into fetal muscle.
Sopper MM; Hauschka SD; Hoffman E; Ontell M
Gene Ther; 1994 Mar; 1(2):108-13. PubMed ID: 7584065
[TBL] [Abstract][Full Text] [Related]
4. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
Luo L; Zhou HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
[TBL] [Abstract][Full Text] [Related]
5. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
6. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
[TBL] [Abstract][Full Text] [Related]
7. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
Kinoshita I; Huard J; Tremblay JP
Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
[TBL] [Abstract][Full Text] [Related]
8. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of treating Duchenne muscular dystrophy with myoblast transplantation].
Liu L; Zhou H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Oct; 23(10):1224-8. PubMed ID: 19957845
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology and the future of myoblast transfer therapy.
Smythe GM; Hodgetts SI; Grounds MD
Mol Ther; 2000 Apr; 1(4):304-13. PubMed ID: 10933948
[TBL] [Abstract][Full Text] [Related]
12. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
Pellegrini KL; Beilharz MW
Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
[TBL] [Abstract][Full Text] [Related]
13. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
15. Absence of MyoD increases donor myoblast migration into host muscle.
Smythe GM; Grounds MD
Exp Cell Res; 2001 Jul; 267(2):267-74. PubMed ID: 11426945
[TBL] [Abstract][Full Text] [Related]
16. [Cell therapy for Duchenne muscular dystrophy].
Zhou C; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):659-61. PubMed ID: 17160947
[TBL] [Abstract][Full Text] [Related]
17. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
18. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
19. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
